Sorafenib Tosylate

規格

475207-59-1CAS番号

641-758-8EC番号

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acidIUPAC名

C28H24ClF3N4O6S化学式

637 g/mol分子量

Sorafenib tosylate; 475207-59-1; Sorafenib tosilate; DTXSID9047839; BAY 54-9085; 5T62Q3B36J; NSC724772; BAY-54-9085; BAY 43-9006 tosylate; DTXCID9027817; CHEBI:50928; 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfonate); 4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE; 1-[4-Chloro-3-(trifluoromethyl)phenyl]-3-[4-[[2-(methylcarbamoyl)pyridin-4-yl]oxy]phenyl]urea mono(4-methylbenzenesulfonate); 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide 4-methylbenzenesulfonate; RefChem:57444; 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic Acid Methyamide-4-methylbenzenesulfonate Tosylate; 641-758-8; 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate; Nexavar; Sorafenib tosylate [USAN]; MFCD08235032; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate); Sorafenib (Tosylate); Sorafenib Hemitosylate; s1040; 2056030-06-7; Sorafenib tosilate (JAN); Sorafenib (Nexavar); Sorafenib tosylate (USAN); Nexavar(R); 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide 4-methylbenzenesulfonate; SORAFENIB TOSILATE [JAN]; MLS002415564; CAS-475207-59-1; NSC-724772; 475207-59-1 (tosylate); NCGC00167488-01; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid; SMR001339079; C28H24ClF3N4O6S; UNII-5T62Q3B36J; SR-00000000529; orafenib tosylate; Sorafenib CRS; BAY43-9006 mono-p-tosylate; BAY 43-9006 mono-p-tosylate; Nexavar (TN); Sorafenib tosilate CRS; SCHEMBL162935; orb1310945; SORAFENIB TOSYLATE [MI]; CHEMBL1200485; SCHEMBL29919725; Sorafenib (Tosylate) (Standard); Sorafenib tosylateBay 43-9006; GLXC-90155; HMS2219E08; HMS3654I09; HMS5079C07; HY-10201AR; Sorafenib (BAY-43-9006)?; SORAFENIB TOSILATE [MART.]; SORAFENIB TOSILATE [WHO-DD]; SORAFENIB TOSYLATE [USP-RS]; Tox21_112489; EBC-17173; HY-10201A; AKOS015924650; AKOS027469919; Tox21_112489_1; AC-6799; CCG-208000; CS-0164; FS10808; ND-0228; Sorafenib tosylate - Bio-X trade mark; SORAFENIB TOSYLATE [ORANGE BOOK]; NCGC00167488-08; SORAFENIB TOSILATE [EP MONOGRAPH]; 2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-, mono(4-methylbenzenesulfonate); 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide 4-methylbenzenesulfonate.; BS164414; SORAFENIB TOSYLATE [USP MONOGRAPH]; SY012324; SW202562-3; D06272; S-8502; SR-00000000529-5; Q27122250; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide tosylate; -(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate); 4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULPHONATE; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide4-methylbenzenesulfonate; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzene-1-sulfonic acid; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-2-pyridinecarboxamide Tosylate; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide;4-methylbenzenesulfonic acid; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide tosylate; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;hydron;4-methylbenzenesulfonate; 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate; 4-{4-[({[4-Chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N -methylpyridine-2-carboxamide tosylate; 4-{4-[({[4-Chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate; 4-{4-[3-(4-Chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy} -pyridine-2-carboxylic acid methylamide-4-methylbenzenesulfonate; 4-{4-[3-(4-Cl-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid methylamide 4-methylbenzenesulfonate; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate; 4-Methylbenzene-1-sulfonic acid--4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide (1/1); Sorafenib Tosylate Micronized別名